DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1020720-04-0, (4,5,6,7-tetradeuterio-1,2-benzoxazol-3-yl)methanesulfonamide, 1,2-benzisoxazole-3-methanesulfonamide-d4, 1,2-benzisoxazole-4,5,6,7-d4-3-methanesulfonamide, 3-(sulfamoylmethyl)-1,2-benzisoxazole-d4, Zonisamid-15n d4

Molecular Formula

C₈H₈N₂O₃S

Molecular Weight

216.25 g/mol

InChI Key

UBQNRHZMVUUOMG-RHQRLBAQSA-N

1 2D Structure

Zonisamide-D4

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4,5,6,7-tetradeuterio-1,2-benzoxazol-3-yl)methanesulfonamide

2.1.2 InChI

InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)/i1D,2D,3D,4D

2.1.3 InChI Key

UBQNRHZMVUUOMG-RHQRLBAQSA-N

2.1.4 Canonical SMILES

C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N

2.1.5 Isomeric SMILES

[2H]C1=C(C(=C2C(=C1[2H])C(=NO2)CS(=O)(=O)N)[2H])[2H]

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 1020720-04-0

2. (4,5,6,7-tetradeuterio-1,2-benzoxazol-3-yl)methanesulfonamide

3. 1,2-benzisoxazole-3-methanesulfonamide-d4

4. 1,2-benzisoxazole-4,5,6,7-d4-3-methanesulfonamide

5. 3-(sulfamoylmethyl)-1,2-benzisoxazole-d4

6. Zonisamid-15n D4

7. 1,2-(benzisoxazole-d4)-3-methanesulfonamide

8. Hy-b0124s

9. Dtxsid30662231

10. Mfcd31560877

11. Akos030243190

12. Cs-0200960

13. J-000620

14. 1-[(~2~h_4_)-1,2-benzoxazol-3-yl]methanesulfonamide

15. [(4,5,6,7-?h?)-1,2-benzoxazol-3-yl]methanesulfonamide

2.3 Create Date

2010-03-29

3 Chemical and Physical Properties

Molecular Formula	C₈H₈N₂O₃S
Molecular Weight	216.25 g/mol
XLogP3	0.2
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	2
Exact Mass	216.05067028 g/mol
Monoisotopic Mass	216.05067028 g/mol
Topological Polar Surface Area	94.6 Å²
Heavy Atom Count	14
Formal Charge	0
Complexity	298
Isotope Atom Count	4
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

ABOUT THIS PAGE

Find Zonisamide-D4 manufacturers, exporters & distributors on PharmaCompass

Zonisamide-D4

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?